KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Goodwill & Intangibles: 2018-2025

Historic Goodwill & Intangibles for Castle Biosciences (CSTL) over the last 5 years, with Sep 2025 value amounting to $101.8 million.

  • Castle Biosciences' Goodwill & Intangibles fell 7.89% to $101.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.8 million, marking a year-over-year decrease of 7.89%. This contributed to the annual value of $106.2 million for FY2024, which is 9.47% down from last year.
  • As of Q3 2025, Castle Biosciences' Goodwill & Intangibles stood at $101.8 million, which was down 2.19% from $104.1 million recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Goodwill & Intangibles registered a high of $132.7 million during Q2 2022, and its lowest value of $32.1 million during Q3 2021.
  • Over the past 3 years, Castle Biosciences' median Goodwill & Intangibles value was $112.8 million (recorded in 2024), while the average stood at $110.1 million.
  • In the last 5 years, Castle Biosciences' Goodwill & Intangibles surged by 306.05% in 2022 and then crashed by 32.31% in 2025.
  • Castle Biosciences' Goodwill & Intangibles (Quarterly) stood at $88.9 million in 2021, then surged by 42.09% to $126.3 million in 2022, then declined by 7.13% to $117.3 million in 2023, then dropped by 9.47% to $106.2 million in 2024, then declined by 7.89% to $101.8 million in 2025.
  • Its last three reported values are $101.8 million in Q3 2025, $104.1 million for Q2 2025, and $77.9 million during Q1 2025.